Entry requirements

Minimum of 1 year full time studies within medicine or biological programs (or similar). Ex) Students in medicine, biomedicine, pharmacy, biomedical engineering, nurse programme or similar.

Learning outcomes

After the course the student should be able to:

Discuss different diseases that can benefit from immune-, gene-, or cell therapy Discuss the principle of immunotherapy

Discuss the principle of gene therapy

Discuss the principle of cell therapy

Describe the role of the immune system in diseases such as cancer and autoimmunity

Discuss adoptive T cell therapy for cancer or infectious disease

Describe the process of Langerhans islet transplantation to patients with diabetes

Discuss how genes can be transferred to patients for therapy (e.g. describe a vector system, ex adenovirus)

Write an essay in the topic of immune-, gene-, or cell therapy with references included.

Content

The course gives an overview of new and established treatments based on immune, gene and cell therapy. The course will discuss new opportunities as well as difficulties with these kind of therapies. Some areas that will be at focus are: transplantation of endocrine cells, immunotherapy of cancer and stem cell transplantation.

Instruction

The course is a seminar series consisting of 10 meetings. The seminars will be held by scientists and/or medical doctors in the field. The seminars will be held in Swedish but upon request they will be held in English.

Assessment

Home examination: written essay

Course level in relation to degree requirements

The course is held at an advanced level within medicine/biology and can be considered as an advanced level course to obtain Bachelor or Master's degree.

Other regulations

Course leader: Angelica Loskog (angelica.loskog@klinimm.uu.se, 018-6119181)